TITLE

Synchronous double primary lung cancers of squamous and neuroendocrine type associated with cryptogenic fibrosing alveolitis

AUTHOR(S)
Seo, J W; Im, J G; Kim, Y W; Kim, J H; Sheppard, M N
PUB. DATE
November 1991
SOURCE
Thorax;Nov1991, Vol. 46 Issue 11, p857
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66017786

 

Related Articles

  • Pulmonary Fibrosis.  // Current Medical Literature: Respiratory Medicine;2010, Vol. 24 Issue 1, p23 

    The article reviews several studies on pulmonary fibrosis. It cites an investigation on the effect of bosentan in patients with idiopathic pulmonary fibrosis (IPF) in the Bosentan Use in Interstitial Lung Disease-1 (BUILD-1) trial which note that endothelin antagonists do not have any proven...

  • Cryptogenic Fibrosing Alveolitis Predating Ulcerative Colitis. De Llano, Luis A. Pérez; Lancho, Angel; Del Cerro, J. L. Soilán; López-Rosés, Leopoldo // American Journal of Gastroenterology;Apr1996, Vol. 91 Issue 4, p822 

    Presents a letter to the editor on cryptogenic fibrosing alveolitis predating ulcerative colitis.

  • Minerva.  // BMJ: British Medical Journal (International Edition);04/11/98, Vol. 316 Issue 7138, p1178 

    Presents information on developments in medicine. Information on injuries from snowmobiles; Account on an approach for treating metastatic breast cancer; Survival period of patients with cryptogenic fibrosing alveolitis.

  • Cryptogenic fibrosing alveolitis and lung cancer: the BTS study. J M Harris // Thorax;Jan2010, Vol. 65 Issue 1, p70 

    BACKGROUND: The risk of lung cancer is often reported to be increased for patients with cryptogenic fibrosing alveolitis (CFA). METHODS: Vital status was sought for all 588 members of the British Thoracic Society (BTS) cryptogenic fibrosing alveolitis (CFA) study 11 years after entry to the...

  • Localisation of transforming growth factor β1 and β3 mRNA transcripts in normal and fibrotic human lung. Coker, R. K.; Laurent, G. J.; Jeffery, P. K.; du Bois, R. M.; Black, C. M.; McAnulty, R. J. // Thorax;Jul2001, Vol. 56 Issue 7, p549 

    Background--Transforming growth factor β1 is implicated in the pathogenesis of lung fibrosis. It promotes extracellular matrix accumulation by increasing procollagen synthesis and reducing degradation. TGFβ1 gene and protein expression increase in experimental lung fibrosis, and TGFβ1...

  • SCIENTIFIC FRONTIERS IN LUNG DISEASE.  // Thorax;Dec2001 Supp, Vol. 56, piii41 

    This article presents various studies related to scientific frontiers in lung disease. The immune pathology of sarcoidosis is characterized by an exaggerated CD4 T cell response to an undefined antigens. Spontaneous remission occurs in the majority of subjects, but 30% of patients develon...

  • What causes cryptogenic fibrosing alveolitis? A case-control study of environmental exposure to dust. Scott, Jonathan; Johnston, Ian; Britton, John // BMJ: British Medical Journal (International Edition);11/3/90, Vol. 301 Issue 6759, p1015 

    Examines the etiology of cryptogenic fibrosing alveolitis in Nottingham, England. Role of the occupational and domestic exposure to dust for the development of the disease; Survival of patients after a month of diagnosed; Evaluation of the restrictive pulmonary function test for the investigation.

  • Rising mortality from cryptogenic fibrosing alveolitis. Johnston, Ian; Britton, John; Kinnear, William; Logan, Richard // BMJ: British Medical Journal (International Edition);11/3/90, Vol. 301 Issue 6759, p1017 

    Examines the mortality rate caused by cryptogenic fibrosing alveolitis in Great Britain. Identification of factors important in the etiology of the disease; Assessment of the validity of death certification of the disease; Treatment and management of the disease.

  • Anti-Jo-1 antibody: a marker for myositis with interstitial lung disease. Bernstein, R.M.; Morgan, S.H.; Chapman, J.; Bunn, C.C.; Mathews, M.B.; Turner-Warick, M.; Hughes, G.R.V. // British Medical Journal (Clinical Research Edition);7/21/1984, Vol. 289 Issue 6438, p151 

    Discusses the function of anti-jo-1 antibody in patients with myositis and cryptogenic fibrosing alveolitis in Great Britain. Definition of myositis; Identification of the antibody by counterimmunoelectrophoresis; Usage of cytotoxic drugs.

  • What is this thing called CFA? Wells, A. U.; Hansell, D. M.; Nicholson, A. G. // Thorax;Jan2007, Vol. 62 Issue 1, p3 

    The article discusses various reports published within the issue, including one by R. Rudd, R.J. Prescott and JC Chalmers regarding cryptogenic fibrosing alveolitis.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics